Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Synthesis and use of novel ET-antagonist series disclosed by Merck KGaA

Nov. 18, 1998

Cytel receives FDA grant to further development of selectin inhibitor

Nov. 18, 1998

Collateral Therapeutics draws nearer to an effective gene therapy for CHF

Nov. 17, 1998

Na+/Ca2+ exchange inhibitors patented by Taisho

Nov. 16, 1998

More news from AHA: azimilide prevents atrial fibrillation

Nov. 16, 1998

New cytokine modulator from Schering-Plough is active in models of endotoxemia

Nov. 13, 1998

Renal protective effect of efonidipine in hypertensive patients

Nov. 13, 1998

Serum complement activation is implicated in the pathogenesis of CHF

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

Data and safety monitoring board recommends continuation of Bextra study

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026